Skip to main content
DR REDDYS LABORATORIES LTD logo

DR REDDYS LABORATORIES LTD — Investor Relations & Filings

Ticker · RDY ISIN · US2561352038 LEI · 335800OVDPY3DVZR2798 BSE.NS Manufacturing
Filings indexed 2,316 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country IN India
Listing BSE.NS RDY

About DR REDDYS LABORATORIES LTD

https://www.drreddys.com/

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings Classification · 88% confidence The document is a comprehensive “Outcome of Board Meeting” notice filed under Indian SEBI Listing Regulations, containing board approvals for audited financial results (quarter and full year), dividend recommendation, AGM convening, director and auditor appointments, and senior management changes. It is submitted as a compliance/regulatory announcement to stock exchanges rather than a standalone annual report (10-K), quarterly interim report (IR), or simple earnings release (ER). It also includes actual financial statements within the filing, so it is not merely announcing the publication of a report (RPA). This falls under the catch-all category for general regulatory filings and disclosures (RNS).
2026-05-12 English
Outcome of Board Meeting held on May 12, 2026
Interim / Quarterly Report Classification · 93% confidence The document is the formal 'Outcome of Board Meeting' filing with stock exchanges under SEBI Listing Regulations. It encloses the company’s Audited Financial Results for the quarter and financial year ended March 31, 2026, including full IFRS P&L, segment information, balance sheet and cash flow statements. This goes beyond a simple earnings highlight and contains substantive financial statements for a period shorter than a full fiscal year (quarter), fitting the definition of an Interim/Quarterly Report rather than an earnings release or a full annual report. Therefore, the appropriate classification is IR. FY 2026
2026-05-12 English
6-K - DR REDDYS LABORATORIES LTD (0001135951) (Filer)
Foreign Filer Report
2026-05-12 English
6-K - DR REDDYS LABORATORIES LTD (0001135951) (Filer)
Foreign Filer Report
2026-05-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 75% confidence The document is an SEBI Listing Obligations disclosure under Regulation 30, informing stock exchanges of the schedule for analyst/institutional investor meetings. It is a routine compliance announcement rather than a full report (e.g., financial results, annual/quarterly report) or specific category like earnings release or investor presentation. It falls under general regulatory filings for compliance announcements.
2026-05-11 English
Intimation of Analyst/Investor meet
Regulatory Filings Classification · 75% confidence The text is a compliance announcement under SEBI Listing Regulations, informing stock exchanges of the company’s upcoming analyst and institutional investor meetings. It does not contain financial data, reports, or presentations; nor is it a meeting material itself. It falls under general regulatory announcements and disclosures under Regulation 30, making it a Regulatory Filing. Therefore, the appropriate category is RNS.
2026-05-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.